1. Home
  2. PTLE vs SYBX Comparison

PTLE vs SYBX Comparison

Compare PTLE & SYBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTLE
  • SYBX
  • Stock Information
  • Founded
  • PTLE 2013
  • SYBX N/A
  • Country
  • PTLE Singapore
  • SYBX United States
  • Employees
  • PTLE N/A
  • SYBX N/A
  • Industry
  • PTLE Oil Refining/Marketing
  • SYBX Biotechnology: Pharmaceutical Preparations
  • Sector
  • PTLE Energy
  • SYBX Health Care
  • Exchange
  • PTLE Nasdaq
  • SYBX Nasdaq
  • Market Cap
  • PTLE 14.7M
  • SYBX 16.5M
  • IPO Year
  • PTLE 2024
  • SYBX N/A
  • Fundamental
  • Price
  • PTLE $1.36
  • SYBX $1.20
  • Analyst Decision
  • PTLE
  • SYBX Hold
  • Analyst Count
  • PTLE 0
  • SYBX 1
  • Target Price
  • PTLE N/A
  • SYBX N/A
  • AVG Volume (30 Days)
  • PTLE 60.1K
  • SYBX 10.2K
  • Earning Date
  • PTLE 02-21-2025
  • SYBX 03-06-2025
  • Dividend Yield
  • PTLE N/A
  • SYBX N/A
  • EPS Growth
  • PTLE N/A
  • SYBX N/A
  • EPS
  • PTLE 0.03
  • SYBX N/A
  • Revenue
  • PTLE $108,126,091.00
  • SYBX $8,000.00
  • Revenue This Year
  • PTLE N/A
  • SYBX N/A
  • Revenue Next Year
  • PTLE N/A
  • SYBX N/A
  • P/E Ratio
  • PTLE $44.93
  • SYBX N/A
  • Revenue Growth
  • PTLE 36.47
  • SYBX N/A
  • 52 Week Low
  • PTLE $1.11
  • SYBX $1.15
  • 52 Week High
  • PTLE $15.78
  • SYBX $2.04
  • Technical
  • Relative Strength Index (RSI)
  • PTLE N/A
  • SYBX 30.51
  • Support Level
  • PTLE N/A
  • SYBX $1.15
  • Resistance Level
  • PTLE N/A
  • SYBX $1.33
  • Average True Range (ATR)
  • PTLE 0.00
  • SYBX 0.07
  • MACD
  • PTLE 0.00
  • SYBX -0.01
  • Stochastic Oscillator
  • PTLE 0.00
  • SYBX 19.23

About PTLE PTL LTD Ordinary Shares

PTL Ltd is a holding company. Through its subsidiaries, it is an established bunkering facilitator providing marine fuel logistics services for vessel refuelling, primarily serving the Asia Pacific market. As a bunker facilitator, the Group's services mainly involve facilitating with its suppliers to supply fuel for the use by the customers' vessels at various ports along their voyages in the Asia Pacific region; arranging vessel refuelling activities at competitive pricing to the customers; offering trade credit to the customers for vessel refuelling; handling unforeseeable circumstances faced by the customers and providing contingency solutions to the customers in a timely manner; and handling disputes, mainly in relation to quality and quantity issues on marine fuel, if any.

About SYBX Synlogic Inc.

Synlogic Inc is a biopharmaceutical company focuses on rare metabolic disorders, with a lead program in phenylketonuria (PKU) and homocystinuria (HCU). The company's pipeline includes therapeutics for enteric hyperoxaluria, gout, and cystinuria. Using a proprietary approach, the company engineer GI-restricted, oral medicines from well-characterized probiotics. These drug candidates target specific biological pathways, leveraging Escherichia coli Nissle 1917 for consistency and safety. Engineered to be non-colonizing and reversible, the company offer oral administration, simplifying shipping and storage. The company operates in one segment-discovery and development of Synthetic Biotics-pioneering transformative treatments for serious diseases.

Share on Social Networks: